CLOV vs INFU · rev $1.37B vs P/E 25, rev $134.9M
Clover Health Investments Corp (CLOV) versus InfuSystems Holdings Inc (INFU) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
InfuSystems Holdings Inc (INFU) is a medical devices company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported INFU revenue for 2024-12-31 was $134.9M. Net income was $2.3M. Revenue was up 7.2% from 2023-12-31 to 2024-12-31. INFU currently screens at market cap $186.5M and trailing P/E 25.0.
CLOV currently screens at market cap $1.55B. INFU currently screens at market cap $186.5M and trailing P/E 25.0.
Not investment advice. Open the CLOV and INFU stock pages for the full models.
Not investment advice.